Open Access
Issue
Med Buccale Chir Buccale
Volume 16, Number 4, novembre 2010
Page(s) 227 - 237
Section Mises au point / Literature reviews
DOI https://doi.org/10.1051/mbcb/2010031
Published online 16 November 2010
  1. Langer R, Vacanti J. Tissue engineering. Science 1993;260:920-6. [CrossRef] [PubMed] [Google Scholar]
  2. Lee KH. Tissue-engineered human living skin substitutes: development and clinical application. Yonsei Med J 2000;41:774-9. [PubMed] [Google Scholar]
  3. Badylak SF, Nerem RM. Progress in tissue engineering and regenerative medicine. Proc Natl Acad Sci USA 2010;107:3285-6. [CrossRef] [Google Scholar]
  4. Mesimäki K, Lindroos B, Törnwall J, Mauno J, Lindqvist C, Kontio R, Miettinen S, Suururonen R. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg 2009;38:201-9. [CrossRef] [PubMed] [Google Scholar]
  5. Orringer JS, Shaw WW, Borud LJ, Freymiller EG, Wang SA, Markowitz BL. Total mandibular and lower lip reconstruction with a prefabricated osteocutaneous free flap. Plast Reconstr Surg 1999;104:793-7. [CrossRef] [PubMed] [Google Scholar]
  6. Warnke PH, Springer ING, Wiltfang J, Acil Y, Eufinger H, Wehmöller M, Russo PAJ, Bolte H, Sherry E, Behrens E, Terheyden H. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004;364:766-70. [CrossRef] [PubMed] [Google Scholar]
  7. Heliotis M, Lavery KM, Ripamonti U, Tsiridis E, Di Silvio L. Transformation of a prefabricated hydroxyapatite/osteogenic protein-1 implant into a vascularised pedicled bone flap in the human chest. Int J Oral Maxillofac Surg 2006;35:265-9. [CrossRef] [PubMed] [Google Scholar]
  8. Kokemueller H, Spalthoff S, Nolff M, Tavassol F, Essig H, Stuehmer C, Bornmann KH, Rücker M, Gellrich NC. Prefabrication of vascularized bioartificial bone grafts in vivo for segmental mandibular reconstruction: experimental pilot study in sheep and first clinical application. Int J Oral Maxillofac Surg 2010;39:379-87. [CrossRef] [PubMed] [Google Scholar]
  9. Goodger N, Wang J, Smagalski G, Hepworth B. Methylmethacrylate as a space maintainer in mandibular reconstruction. J Oral Maxillofac Surg 2005;63:1048-51. [CrossRef] [PubMed] [Google Scholar]
  10. Moghadam HG, Urist MR, Sandor GK, Clokie CM. Successful mandibular reconstruction using a BMP bioimplant. J Craniofac Surg 2001;12:119-27. [CrossRef] [PubMed] [Google Scholar]
  11. Ferretti C, Ripamonti U. Human segmental mandibular defects treated with naturally derived bone morphogenetic proteins. J Craniofac Surg 2002;13:434-44. [CrossRef] [PubMed] [Google Scholar]
  12. Warnke PH, Coren AJ. First experiences with recombinant human bone morphogenetic protein 7 (osteogenic protein 1) in a human case in maxillofacial surgery. Plast Reconstr Surg 2003;111:2471-2. [CrossRef] [PubMed] [Google Scholar]
  13. Warnke PH, Wiltfang J, Springer I, Acil Y, Bolte H, Kosmahl M, Russo P, Sherry E, Lützen U, Wolfart S, Terheyden H. Man as living bioreactor: fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials 2006;27:3163-7. [CrossRef] [PubMed] [Google Scholar]
  14. Pradel W, Eckelt U, Lauer G. Bone regeneration after enucleation of mandibular cysts: comparing autogenous grafts from tissue-engineered bone and iliac bone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:285-90. [CrossRef] [PubMed] [Google Scholar]
  15. Hibi H, Yamada Y, Kagami H, Ueda M. Distraction osteogenesis assisted by tissue engineering in an irradiated mandible: a case report. Int J Oral Maxillofac Implants 2006;21:141-7. [PubMed] [Google Scholar]
  16. Carter TG, Brar PS, Tolas A, Beirne OR. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg 2008; 66:1417-25. [CrossRef] [PubMed] [Google Scholar]
  17. Clokie CML, Sándor GKB. Reconstruction of 10 major mandibular defects using bioimplants containing BMP-7. J Can Dent Assoc 2008;74:67-72. [PubMed] [Google Scholar]
  18. Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 2008;66:616-24. [CrossRef] [PubMed] [Google Scholar]
  19. Zwetyenga N, Catros S, Emparanza A, Deminiere C, Siberchicot F, Fricain JC. Mandibular reconstruction using induced membranes with autologous cancellous bone graft and HA-betaTCP: animal model study and preliminary results in patients. Int J Oral Maxillofac Surg 2009;38:1289-97. [CrossRef] [PubMed] [Google Scholar]
  20. Schuckert K, Jopp S, Teoh S. Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: de novo synthesis of bone in a single case. Tissue Eng Part A 2009;15:493-9. [CrossRef] [PubMed] [Google Scholar]
  21. Lee J, Sung H, Jang J, Park Y, Min S, Kim E. Successful reconstruction of 15-cm segmental defects by bone marrow stem cells and resected autogenous bone graft in central hemangioma. J Oral Maxillofac Surg 2010;68:188-94. [CrossRef] [PubMed] [Google Scholar]
  22. Catros S, Zwetyenga N, Bareille R, Brouillaud B, Renard M, Amédée J, Fricain JC. Subcutaneous induced membranes have no osteoinductive effect on macroporous ha-TCP in vivo. J Orthop Res 2008;27:155-61. [CrossRef] [Google Scholar]
  23. Masquelet AC, Fitoussi F, Begue T, Muller GP. Reconstruction of the long bones by the induced membrane and spongy autograft. Ann Chir Plast Esthet 2000;45:346-53. [PubMed] [Google Scholar]
  24. Masquelet AC, Begue T. The concept of induced membrane for reconstruction of long bone defects. Orthop Clin North Am 2010;41:27-37. [CrossRef] [PubMed] [Google Scholar]
  25. Carstens MH, Chin M, Ng T, Tom WK. Reconstruction of #7 facial cleft with distraction-assisted in situ osteogenesis (DISO): role of recombinant human bone morphogenetic protein-2 with Helistat-activated collagen implant. J Craniofac Surg 2005;16:1023-32. [CrossRef] [PubMed] [Google Scholar]
  26. Tom WK, Chin M, Ng T, Bouchoucha S, Carstens M. Distraction of rhBMP-2-generated mandible: how stable is the engineered bone in response to subsequent surgeries? J Oral Maxillofac Surg 2008;66:1499-505. [CrossRef] [PubMed] [Google Scholar]
  27. Hibi H, Yamada Y, Ueda M, Endo Y. Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac Surg 2006;35:551-5. [CrossRef] [PubMed] [Google Scholar]
  28. Pradel W, Tausche E, Gollogly J, Lauer G. Spontaneous tooth eruption after alveolar cleft osteoplasty using tissue-engineered bone: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:440-4. [PubMed] [Google Scholar]
  29. Behnia H, Khojasteh A, Soleimani M, Tehranchi A, Khoshzaban A, Keshel SH, Atashi R. Secondary repair of alveolar clefts using human mesenchymal stem cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:e1-6. [CrossRef] [Google Scholar]
  30. Chin M, Ng T, Tom WK, Carstens M. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Craniofac Surg 2005;16:778-89. [CrossRef] [PubMed] [Google Scholar]
  31. Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, Boyne PJ. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009;67:1947-60. [CrossRef] [PubMed] [Google Scholar]
  32. Beaumont C, Schmidt RJ, Tatakis DN, Zafiropoulos G. Use of engineered bone for sinus augmentation. J Periodontol 2008;79:541-8. [CrossRef] [PubMed] [Google Scholar]
  33. Mangano C, Piattelli A, Mangano A, Mangano F, Mangano A, Iezzi G, Borges F, d’Avila S, Shibli J. Combining scaffolds and osteogenic cells in regenerative bone surgery: a preliminary histological report in human maxillary sinus augmentation. Clin Implant Dent Relat Res 2009;11:e92-102. [CrossRef] [PubMed] [Google Scholar]
  34. VossP, Sauerbier S, Wiedmann-Al-Ahmad M, Zizelmann C, Stricker A, Schmelzeisen R, Gutwald R. Bone regeneration in sinus lifts: comparing tissue-engineered bone and iliac bone. Br J Oral Maxillofac Surg 2010;48:121-6. [CrossRef] [PubMed] [Google Scholar]
  35. Schmelzeisen R, Schimming R, Sittinger M. Making bone: implant insertion into tissue-engineered bone for maxillary sinus floor augmentation-a preliminary report. J Craniomaxillofac Surg 2003;31:34-9. [CrossRef] [PubMed] [Google Scholar]
  36. Schimming R, Schmelzeisen R. Tissue-engineered bone for maxillary sinus augmentation. J Oral Maxillofac Surg 2004;62:724-9. [CrossRef] [PubMed] [Google Scholar]
  37. Strietzel FP. Tissue-engineered bone for lateral alveolar ridge augmentation: a case report. Int J Oral Maxillofac Implants 2006;21:131-5. [PubMed] [Google Scholar]
  38. Springer IN, Nocini PF, Schlegel KA, De Santis D,Park J, Warnke PH, Terheyden H, Zimmermann R, Chiarini L, Gardner K, Ferrari F, Wiltfang J. Two techniques for the preparation of cell-scaffold constructs suitable for sinus augmentation: steps into clinical application. Tissue Eng 2006;12:2649-56. [CrossRef] [PubMed] [Google Scholar]
  39. Yamamiya K, Okuda K, Kawase T, Hata K, Wolff LF, Yoshie H. Tissue-engineered cultured periosteum used with platelet-rich plasma and hydroxyapatite in treating human osseous defects. J Periodontol 2008;79:811-8. [CrossRef] [PubMed] [Google Scholar]
  40. d’Aquino R, De Rosa A,Lanza V, Tirino V, Laino L, Graziano A, Desiderio V, Laino G, Papaccio G. Human mandible bone defect repair by the grafting of dental pulp stem/progenitor cells and collagen sponge biocomplexes. Eur Cell Mater 2009;18:75-83. [CrossRef] [PubMed] [Google Scholar]
  41. Kulakov AA, Goldshtein DV, Grigoryan AS, Rzhaninova AA, Alekseeva IS, Arutyunyan IV, Volkov AV. Clinical study of the efficiency of combined cell transplant on the basis of multipotent mesenchymal stromal adipose tissue cells in patients with pronounced deficit of the maxillary and mandibulary bone tissue. Bull Exp Biol Med 2008;146:522-5. [CrossRef] [PubMed] [Google Scholar]
  42. Yamada Y, Nakamura S, Ito K, Kohgo T, Hibi H, Nagasaka T, Ueda M. Injectable tissue-engineered bone using autogenous bone marrow-derived stromal cells for maxillary sinus augmentation: clinical application report from a 2-6-year follow-up. Tissue Eng Part A 2008;14:1699-707. [CrossRef] [PubMed] [Google Scholar]
  43. Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M, Khoshzaban A, Ahmadbeigi N. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:203-9. [CrossRef] [PubMed] [Google Scholar]
  44. Ueda M, Yamada Y, Kagami H, Hibi H. Injectable bone applied for ridge augmentation and dental implant placement: human progress study. Implant Dent 2008;17:82-90. [CrossRef] [PubMed] [Google Scholar]
  45. Zizelmann C, Schoen R, Metzger MC, Schmelzeisen R, Schramm A, Dott B, Bormann K, Gellrich N. Bone formation after sinus augmentation with engineered bone. Clin Oral Implants Res 2007;18:69-73. [CrossRef] [PubMed] [Google Scholar]
  46. Fuerst G, Strbac GD, Vasak C, Tangl S, Leber J, Gahleitner A, Gruber R, Watzek G. Are culture-expanded autogenous bone cells a clinically reliable option for sinus grafting? Clin Oral Implants Res 2009;20:135-9. [CrossRef] [PubMed] [Google Scholar]
  47. Koch FP, Becker J, Terheyden H, Capsius B, Wagner W. A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor-5 coated onto beta-tricalcium phosphate for sinus lift augmentation. Clin Oral Implants Res 2010 Jun 8 [Epub ahead of print]. [Google Scholar]
  48. Schuckert K, Jopp S, Osadnik M. Modern bone regeneration instead of bone transplantation: a combination of recombinant human bone morphogenetic protein-2 and platelet-rich plasma for the vertical augmentation of the maxillary bone-A single case report. Tissue Eng Part C Methods 2010 Apr 26 [Epub ahead of print]. [Google Scholar]
  49. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000;71:1241-57. [CrossRef] [PubMed] [Google Scholar]
  50. Jung RE, Glauser R, Schärer P, Hämmerle CHF, Sailer HF, Weber FE. Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 2003;14:556-68. [CrossRef] [PubMed] [Google Scholar]
  51. Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, Triplett RG. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005;63:1693-707. [CrossRef] [PubMed] [Google Scholar]
  52. Yamada Y, Ueda M, Hibi H, Nagasaka T. Translational research for injectable tissue-engineered bone regeneration using mesenchymal stem cells and platelet-rich plasma: from basic research to clinical case study. Cell Transplant 2004;13:343-55. [CrossRef] [PubMed] [Google Scholar]
  53. Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA. Cell based bone tissue engineering in jaw defects. Biomaterials 2008;29:3053-61. [CrossRef] [PubMed] [Google Scholar]
  54. Haute Autorité de Santé. Guide d’analyse de la littérature et gradation des recommandations 2000. [Google Scholar]
  55. Baqain ZH, Anabtawi M, Karaky AA, Malkawi Z. Morbidity from anterior iliac crest bone harvesting for secondary alveolar bone grafting: an outcome assessment study. J Oral Maxillofac Surg 2009;67:570-5. [CrossRef] [PubMed] [Google Scholar]
  56. Schaaf H, Lendeckel S, Howaldt H, Streckbein P. Donor site morbidity after bone harvesting from the anterior iliac crest. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:52-8. [CrossRef] [PubMed] [Google Scholar]
  57. Boyapati L, Wang H. The role of platelet-rich plasma in sinus augmentation: a critical review. Implant Dent 2006;15:160-70. [CrossRef] [PubMed] [Google Scholar]
  58. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62:489-96. [CrossRef] [PubMed] [Google Scholar]
  59. Gimbel M, Ashley RK, Sisodia M, Gabbay JS, Wasson KL, Heller J, Wilson L, Kawamoto H, Bradley J. Repair of alveolar cleft defects: reduced morbidity with bone marrow stem cells in a resorbable matrix. J Craniofac Surg 2007;18:895-901. [CrossRef] [PubMed] [Google Scholar]
  60. Mosna F, Sensebé L, Krampera M. Human bone-marrow and adipose tissue mesenchymal stem cells: a user’s guide. Stem Cells Dev 2010; sous presse. [Google Scholar]
  61. Ebara S, Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 2002;27:S10-5. [CrossRef] [PubMed] [Google Scholar]
  62. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Börner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Rüter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84:2123-34. [PubMed] [Google Scholar]
  63. Chao M, Donovan T, Sotelo C, Carstens MH. In situ osteogenesis of hemimandible with rhBMP-2 in a 9-year-old boy: osteoinduction via stem cell concentration. J Craniofac Surg 2006;17:405-12. [CrossRef] [PubMed] [Google Scholar]
  64. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol 2004;22:80-6. [CrossRef] [PubMed] [Google Scholar]
  65. Pelissier P, Masquelet AC, Bareille R, Pelissier SM, Amedee J. Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J Orthop Res 2004;22:73-9. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.